U.S. stocks gave up earlier gains as the energy sector continued to sell off despite relatively stable crude prices on Tuesday. Fresh data on the labor market helped to support the Federal Reserve's decision to hike rates for the first time in nearly a decade last year. Job openings climbed their second-highest level ever in December, the same month the central bank moved on rates. Regeneron Pharmaceuticals (REGN) fell on disappointing sales of its key eye-disease drug. Sales of Eylea increased 44% in its fourth quarter, slowing from 65% growth a quarter earlier. 21st Century Fox (FOXA) slid as a weaker quarter for its film business dragged on overall revenue. Meanwhile, Fox News scored its 73rd straight quarter of profit growth thanks to increased political coverage this election cycle. TheStreet's Keris Lahiff reports from Wall Street.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.